Dongxue Zhang1, Bojun Wei2,3, Long Li4, Tao Jiang5, Xiaoai Yao1, Xin Liu6, Yuyan Sun1. 1. Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Haidian District, Beijing, 100038, China. 2. Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. 3. Department of Otorhinolaryngology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. 4. Department of Pediatric Surgery, Capital Institute of Pediatrics, Beijing, 100020, China. 5. Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, No.10 Tieyi Road, Haidian District, Beijing, 100038, China. jiangtao6392@126.com. 6. Department of Medical Genetics and Developmental Biology, Capital Medical University, Beijing, 100069, China.
Abstract
BACKGROUND: Dysregulated lncRNA score and PVT1 expression may be involved in cancer. However, relationships of lncRNAs with hyperparathyroidism and parathyroid cancer (PC) diagnosis remain mysterious. METHODS: Using quantitative real-time polymerase chain reaction (RT-qPCR), expression profile of PVT1 was evaluated in 57 patients with primary hyperparathyroidism, including 11 with parathyroid cancer (PC) and 46 with parathyroid adenoma (PA). RESULTS: Higher levels of lncRNA score and PVT1 expression were associated with increased serum calcium level after water ingestion and PC risk (P < 0.05). Accordingly, lncRNA score and PVT1 expression were increased with varying degrees of hypercalcemia in PC. A higher level of lncRNA score (but not PVT1) was an independent risk factor of PC, with an AUC up to 0.872 (95% CI: 0.756-0.945, P < 0.001). Moreover, lncRNA score was more valuable (with AUC 0.974, sensitivity of 85.71% and specificity of 100%, respectively) than intact parathyroid hormone (iPTH) in predicting risk of PC among patients with hypercalcemia (especially based on greater AUC, P = 0.010). CONCLUSION: Increased lncRNA score is correlated with an elevated level of serum calcium, which may serve as a potential biomarker for PC diagnosis, especially with hypercalcemia.
BACKGROUND: Dysregulated lncRNA score and PVT1 expression may be involved in cancer. However, relationships of lncRNAs with hyperparathyroidism and parathyroid cancer (PC) diagnosis remain mysterious. METHODS: Using quantitative real-time polymerase chain reaction (RT-qPCR), expression profile of PVT1 was evaluated in 57 patients with primary hyperparathyroidism, including 11 with parathyroid cancer (PC) and 46 with parathyroid adenoma (PA). RESULTS: Higher levels of lncRNA score and PVT1 expression were associated with increased serum calcium level after water ingestion and PC risk (P < 0.05). Accordingly, lncRNA score and PVT1 expression were increased with varying degrees of hypercalcemia in PC. A higher level of lncRNA score (but not PVT1) was an independent risk factor of PC, with an AUC up to 0.872 (95% CI: 0.756-0.945, P < 0.001). Moreover, lncRNA score was more valuable (with AUC 0.974, sensitivity of 85.71% and specificity of 100%, respectively) than intact parathyroid hormone (iPTH) in predicting risk of PC among patients with hypercalcemia (especially based on greater AUC, P = 0.010). CONCLUSION: Increased lncRNA score is correlated with an elevated level of serum calcium, which may serve as a potential biomarker for PC diagnosis, especially with hypercalcemia.
Entities:
Keywords:
Hypercalcemia; LncRNA score; PVT1; Parathyroid cancer
Authors: Robert Romano; Chen-Pang Soong; Madison Rose; Jessica Costa-Guda; Justin Bellizzi; Andrew Arnold Journal: Endocrine Date: 2016-10-14 Impact factor: 3.633
Authors: Michael Schaapveld; Francisca H Jorna; Katja K H Aben; Harm R Haak; John T M Plukker; Thera P Links Journal: Am J Surg Date: 2011-08-20 Impact factor: 2.565
Authors: Minna Pekkinen; Mikael E B Ahlström; Ulrike Riehle; Minna M Huttunen; Christel J E Lamberg-Allardt Journal: Bone Date: 2008-03-12 Impact factor: 4.398
Authors: Wenberger Lanza Daniel de Figueiredo; Eraldo Ferreira Lopes; Deborah Laredo Jezini; Lorena Naciff Marçal; Enedina Nogueira de Assunção; Paulo Rodrigo Ribeiro Rodrigues; Adolfo José da Mota; Diego Monteiro de Carvalho; Spartaco Astolfi Filho; João Bosco Lopes Botelho Journal: PLoS One Date: 2022-05-20 Impact factor: 3.752